- Q3 2025 sales were €1.34 billion, a 6% decrease from Q3 2024.
- EBITDA for Q3 2025 was €112 million, down 23% year over year.
- Net result for Q3 2025 was negative at €-82 million.
- Full-year EBITDA is confirmed in the lower half of the expected range.
Q3 2025 Financial Performance
Wacker Chemie AG reported a 6% decline in sales for Q3 2025, totaling €1.34 billion compared to €1.43 billion in Q3 2024. This decrease was driven by lower prices and adverse exchange-rate effects. Compared to Q2 2025, sales fell by 5% from €1.41 billion.
EBITDA and Net Results
The Group's EBITDA for Q3 2025 was €112 million, a 23% drop from €145 million in the same period last year. The decline was attributed to reduced sales volumes, prices, and plant capacity utilization, alongside unfavorable EUR/USD exchange rates. The EBITDA margin for the quarter was 8.3%, down from 10.2% in Q3 2024 and slightly above the 8.1% in Q2 2025. The net result for Q3 2025 was negative at €-82 million, with earnings per share at €-1.73.
Market Expectations and EBIT
Third-quarter sales and earnings aligned with market expectations, which estimated Group sales at €1.37 billion and EBITDA at €101 million. Group EBIT fell significantly to €-20 million from €30 million in Q3 2024, resulting in an EBIT margin of -1.5% compared to 2.1% in the previous year.
Outlook
WACKER confirmed its full-year EBITDA would be in the lower half of the expected range. CEO Christian Hartel emphasized the company's focus on cash and cost management amid declining sales and earnings across most business divisions.
